Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 970
Publisher
MDPI AG
Online
2019-07-11
DOI
10.3390/cancers11070970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility
- (2019) Gloria Ravegnini et al. Epigenetics
- Upregulation of miR-125b, miR-181d, and miR-221 Predicts Poor Prognosis in MGMT Promoter-Unmethylated Glioblastoma Patients
- (2018) Yen-Ying Chen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells
- (2018) Qihui Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion
- (2018) Lin Liu et al. Cancer Biomarkers
- Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer
- (2018) Juan Gu et al. CANCER LETTERS
- MiRNA-221/222 in thyroid cancer: A meta-analysis
- (2018) Ling Liang et al. CLINICA CHIMICA ACTA
- MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma
- (2018) Ningji Gong et al. MEDICINE
- Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer
- (2018) Michihisa Iida et al. ONCOLOGY REPORTS
- Classification of miRNA-related sequence variations
- (2018) Karin Hrovatin et al. Epigenomics
- Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
- (2018) Jens C. Hahne et al. Frontiers in Oncology
- MicroRNAs in cancer drug resistance: Basic evidence and clinical applications
- (2018) Mehri Ghasabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy
- (2018) Mohammad Mohajeri et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC
- (2018) Yiyan Lei et al. OncoTargets and Therapy
- The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients
- (2018) Pengfei Zhang et al. Cancer Management and Research
- miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression
- (2017) Foteini D. Tsikrika et al. GENES CHROMOSOMES & CANCER
- miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma
- (2017) Olfat Shaker et al. INFECTION GENETICS AND EVOLUTION
- MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1
- (2017) Tong Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer
- (2017) Song-Hee Han et al. Journal of Breast Cancer
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Expression and prognostic significance of miR-375 and miR-221 in liver cancer
- (2017) Dafei Xie et al. Oncology Letters
- Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
- (2017) Ling Deng et al. Oncotarget
- MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer
- (2017) Yongwen Li et al. Journal of Cancer
- Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
- (2017) Jialin Song et al. Frontiers in Immunology
- Screening and validation of lncRNAs and circRNAs as miRNA sponges
- (2016) Giuseppe Militello et al. BRIEFINGS IN BIOINFORMATICS
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma
- (2016) Xiao-yan He et al. CLINICAL CANCER RESEARCH
- The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis
- (2016) Liang Xue et al. NEUROLOGICAL SCIENCES
- Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients
- (2016) Yahui Zhang et al. TUMOR BIOLOGY
- MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival
- (2016) Xiaodan Fu et al. Oncotarget
- MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
- (2015) Yusuke Goto et al. BRITISH JOURNAL OF CANCER
- Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
- (2015) J.-J. Zhao et al. CANCER RESEARCH
- Prognostic and biological significance of microRNA-221 in breast cancer
- (2015) Sanaa Eissa et al. GENE
- Identification of a Metastasis-Specific MicroRNA Signature in Human Colorectal Cancer
- (2015) Keun Hur et al. JNCI-Journal of the National Cancer Institute
- miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers
- (2015) Margherita Nannini et al. Epigenomics
- Identification of a Metastasis-Specific MicroRNA Signature in Human Colorectal Cancer
- (2015) Keun Hur et al. JNCI-Journal of the National Cancer Institute
- miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma
- (2015) Jianguo Li et al. PLoS One
- Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
- (2014) Benedek Gyöngyösi et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma
- (2014) Xinxing Li et al. MOLECULAR NEUROBIOLOGY
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
- (2014) Daniel Claudius Vergho et al. PLoS One
- MicroRNA-222 Expression and Its Prognostic Potential in Non-Small Cell Lung Cancer
- (2014) Kai-ping Mao et al. TheScientificWorldJOURNAL
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Increased expression of miR-222 is associated with poor prognosis in bladder cancer
- (2014) Dong-qing Zhang et al. World Journal of Surgical Oncology
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases
- (2013) Ernest K Amankwah et al. ASIAN JOURNAL OF ANDROLOGY
- MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
- (2013) C M M Gits et al. BRITISH JOURNAL OF CANCER
- Decreased Levels of miR-224 and the Passenger Strand of miR-221 Increase MBD2, Suppressing Maspin and Promoting Colorectal Tumor Growth and Metastasis in Mice
- (2013) Kefei Yuan et al. GASTROENTEROLOGY
- Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance
- (2013) K Liu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis
- (2013) ChongLek Lee et al. MEDICAL ONCOLOGY
- Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions
- (2013) Saakshi Jalali et al. PLoS One
- Exploring Novel Therapeutic Targets in GIST: Focus on the PI3K/Akt/mTOR Pathway
- (2013) Shreyaskumar Patel Current Oncology Reports
- miRNA sponges: soaking up miRNAs for regulation of gene expression
- (2013) Rasmus O. Bak et al. Wiley Interdisciplinary Reviews-RNA
- Do microRNA 96, 145 and 221 expressions really aid in the prognosis of prostate carcinoma?
- (2012) Sung Gu Kang et al. ASIAN JOURNAL OF ANDROLOGY
- Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
- (2012) Jason Hanna et al. BIOTECHNIQUES
- Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma
- (2012) Baek-Hui Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
- (2012) Chunzhi Zhang et al. Journal of Translational Medicine
- MicroRNA profiling: approaches and considerations
- (2012) Colin C. Pritchard et al. NATURE REVIEWS GENETICS
- Prognostic MicroRNAs in Cancer Tissue from Patients Operated for Pancreatic Cancer—Five MicroRNAs in a Prognostic Index
- (2012) Nicolai A. Schultz et al. WORLD JOURNAL OF SURGERY
- MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
- (2011) A. J. Alencar et al. CLINICAL CANCER RESEARCH
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma
- (2011) Sun Och Yoon et al. HUMAN PATHOLOGY
- miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells
- (2011) Chun-Ju Yang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- MicroRNAs expression signatures are associated with lineage and survival in acute leukemias
- (2010) Yungui Wang et al. BLOOD CELLS MOLECULES AND DISEASES
- MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
- (2010) Q. W-L. Wong et al. CLINICAL CANCER RESEARCH
- Quantitative Expression Profiling in Formalin-Fixed Paraffin-Embedded Samples by Affymetrix Microarrays
- (2010) Diana Abdueva et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- Directed attachment of antibodies to kinesin-powered molecular shuttles
- (2009) Amanda Carroll-Portillo et al. BIOTECHNOLOGY AND BIOENGINEERING
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
- (2009) L. Gramantieri et al. CLINICAL CANCER RESEARCH
- Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence
- (2009) Martin Spahn et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
- (2009) Annika Schaefer et al. INTERNATIONAL JOURNAL OF CANCER
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
- (2009) Thomas Greither et al. INTERNATIONAL JOURNAL OF CANCER
- Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
- (2009) Young-Kook Kim et al. NUCLEIC ACIDS RESEARCH
- Amplification and Overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in Medulloblastoma
- (2009) Yuan Lu et al. PLoS One
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
- (2008) R. Medina et al. CANCER RESEARCH
- Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters
- (2008) Andrea Ventura et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More